325 related articles for article (PubMed ID: 20863413)
1. Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD.
Roos-Engstrand E; Pourazar J; Behndig AF; Blomberg A; Bucht A
Respir Res; 2010 Sep; 11(1):128. PubMed ID: 20863413
[TBL] [Abstract][Full Text] [Related]
2. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
3. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects.
Hodge S; Hodge G; Nairn J; Holmes M; Reynolds PN
COPD; 2006 Dec; 3(4):179-87. PubMed ID: 17361498
[TBL] [Abstract][Full Text] [Related]
4. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
5. The expression of lymphocyte surface antigens in bronchial biopsies, bronchoalveolar lavage cells and blood cells in healthy smoking and never-smoking men, 60 years old.
Ekberg-Jansson A; Andersson B; Avrå E; Nilsson O; Löfdahl CG
Respir Med; 2000 Mar; 94(3):264-72. PubMed ID: 10783938
[TBL] [Abstract][Full Text] [Related]
6. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction.
Forsslund H; Mikko M; Karimi R; Grunewald J; Wheelock ÅM; Wahlström J; Sköld CM
Chest; 2014 Apr; 145(4):711-722. PubMed ID: 24264182
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway.
Hodge G; Mukaro V; Holmes M; Reynolds PN; Hodge S
Respirology; 2013 Feb; 18(2):369-76. PubMed ID: 23062183
[TBL] [Abstract][Full Text] [Related]
8. Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).
Leckie MJ; Jenkins GR; Khan J; Smith SJ; Walker C; Barnes PJ; Hansel TT
Thorax; 2003 Jan; 58(1):23-9. PubMed ID: 12511714
[TBL] [Abstract][Full Text] [Related]
9. Increased intraepithelial (CD103+) CD8+ T cells in the airways of smokers with and without chronic obstructive pulmonary disease.
Mikko M; Forsslund H; Cui L; Grunewald J; Wheelock AM; Wahlström J; Sköld CM
Immunobiology; 2013 Feb; 218(2):225-31. PubMed ID: 22652413
[TBL] [Abstract][Full Text] [Related]
10. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
11. CD4-regulatory cells in COPD patients.
Smyth LJ; Starkey C; Vestbo J; Singh D
Chest; 2007 Jul; 132(1):156-63. PubMed ID: 17505034
[TBL] [Abstract][Full Text] [Related]
12. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.
Borchers MT; Wesselkamper SC; Curull V; Ramirez-Sarmiento A; Sánchez-Font A; Garcia-Aymerich J; Coronell C; Lloreta J; Agusti AG; Gea J; Howington JA; Reed MF; Starnes SL; Harris NL; Vitucci M; Eppert BL; Motz GT; Fogel K; McGraw DW; Tichelaar JW; Orozco-Levi M
J Clin Invest; 2009 Mar; 119(3):636-49. PubMed ID: 19197141
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the expression of lymphocyte activation markers in blood, bronchial biopsies and bronchoalveolar lavage: evidence for an enrichment of activated T lymphocytes in the bronchoalveolar space.
Ekberg-Jansson A; Arvå E; Nilsson O; Löfdahl CG; Andersson B
Respir Med; 1999 Aug; 93(8):563-70. PubMed ID: 10542990
[TBL] [Abstract][Full Text] [Related]
14. Expansion of CD4+CD25+ helper T cells without regulatory function in smoking and COPD.
Roos-Engstrand E; Pourazar J; Behndig AF; Bucht A; Blomberg A
Respir Res; 2011 Jun; 12(1):74. PubMed ID: 21651772
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
Freeman CM; Han MK; Martinez FJ; Murray S; Liu LX; Chensue SW; Polak TJ; Sonstein J; Todt JC; Ames TM; Arenberg DA; Meldrum CA; Getty C; McCloskey L; Curtis JL
J Immunol; 2010 Jun; 184(11):6504-13. PubMed ID: 20427767
[TBL] [Abstract][Full Text] [Related]
16. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
[TBL] [Abstract][Full Text] [Related]
17. Imbalance between subpopulations of regulatory T cells in COPD.
Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
[TBL] [Abstract][Full Text] [Related]
18. Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.
Freeman CM; Stolberg VR; Crudgington S; Martinez FJ; Han MK; Chensue SW; Arenberg DA; Meldrum CA; McCloskey L; Curtis JL
PLoS One; 2014; 9(7):e103840. PubMed ID: 25078269
[TBL] [Abstract][Full Text] [Related]
19. ADAM15 expression is increased in lung CD8
Wang X; Zhang D; Higham A; Wolosianka S; Gai X; Zhou L; Petersen H; Pinto-Plata V; Divo M; Silverman EK; Celli B; Singh D; Sun Y; Owen CA
Respir Res; 2020 Jul; 21(1):188. PubMed ID: 32677970
[TBL] [Abstract][Full Text] [Related]
20. Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects.
Ancochea J; González A; Sánchez MJ; Aspa J; López-Botet M
Chest; 1993 Jul; 104(1):32-7. PubMed ID: 8325105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
